LOCATION
Cardurion Pharmaceuticals is a biotechnology company founded in 2017 by physician-scientists Michael E. Mendelsohn, M.D. and Daniel Bloomfield, M.D. Operating within the biotechnology research industry, Cardurion Pharmaceuticals is focused on the development of groundbreaking therapeutics for cardiovascular diseases, especially heart failure and arrhythmias. Through innovative clinical programs involving PDE9 and CaMKII inhibition, the company aims to address unmet medical needs in cardiovascular healthcare. With about 50-74 employees, Cardurion Pharmaceuticals continues its mission to advance clinical-stage biotechnology innovations from its headquarters in Burlington, Massachusetts.
Cardurion Pharmaceuticals has established a strategic office footprint to support its growth in the biotechnology sector. The Cardurion Pharmaceuticals headquarters is located in Burlington, Massachusetts—a key hub for life sciences innovation. The company's presence also extends to Boston, Massachusetts, supporting clinical-stage research, as well as Shonan, Japan, which drives its international research and development operations. Cardurion’s expansion into these regions reflects its commitment to global innovation in cardiovascular therapeutics, providing both a strong domestic foundation and access to international research networks.
The primary Cardurion Pharmaceuticals headquarters is situated at 78 Blanchard Road Suite 200, Burlington, MA 01803, United States. This facility serves as the company’s central hub for biotechnology research and the development of novel cardiovascular therapeutics. Located in the vibrant Greater Boston life sciences cluster, the Cardurion Pharmaceuticals headquarters offers access to academic partnerships, industry talent, and key collaborators, positioning the organization at the forefront of cardiovascular drug development.
The Boston office of Cardurion Pharmaceuticals supports clinical-stage biotechnology research and development for cardiovascular diseases. This location leverages Boston’s world-renowned healthcare and research ecosystem, providing vital resources and expertise for advancing Cardurion’s clinical programs. The Boston office plays a critical role in executing research initiatives and engaging with local academic and industry partners.
Cardurion Pharmaceuticals maintains an office in Shonan, Japan, which supports its international research and development efforts in cardiovascular therapeutics. This location is instrumental in expanding Cardurion’s global reach and fostering collaborations across Asia. The Shonan facility underscores the company’s strategy to access global clinical trial networks and scientific expertise, accelerating the development of cardiovascular medicines on a worldwide scale.
Websets is a powerful natural language search and data enrichment tool that helps you discover comprehensive office and headquarters information for any company. Whether you're researching Cardurion Pharmaceuticals' global footprint or exploring office locations for other organizations, Websets provides detailed insights into headquarters addresses, office types, and geographic presence.
With Websets, you can access detailed office profiles, headquarters data, and location insights through intuitive natural language queries. Sign up now to enhance your office and headquarters research capabilities.